Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration

Author(s):  Driscoll David F, Deaconess Beth Israel, Lawrence Kenneth R, Lewis Keith, Bistrian Bruce R

Issue:  Mar/Apr 1997 - Pediatric Care
View All Articles in Issue

Page(s):  118-120

Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration Page 1
Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration Page 2
Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration Page 3

Download in electronic PDF format for $75

Abstract:  The Centers for Disease Control has identified intravenous propofol, a lipid-based medication, as a cause of postoperative infections in hospitalized patients. It appears the increased risk results from poor aseptic technique in the preparation, storage and administration of extemporaneously prepared propofol infusions. An additional risk of preparing propofol injection includes glass particulate contamination when the ampule dosage form is used. The current study, therefore, examines the extrinsic particulate load between propofol syringes prepared from ampules and vials with and without the use of a filter needle.

Ten operating room clinicians were asked to prepare propofol infusion from ampules using a standard needle and a special filter needle. A similar comparison was performed separately in the laboratory using propofol vials to deduce differences between the normal presence of fat globules and the adventitious introduction of glass particulates from propofol ampules. Particle size analysis was determined by a single-particle, opticalsensing device using laser light extinction. Aliquots of the unfiltered and filtered samples were analyzed in triplicate by number-weighting all particles = 1.75 µm (instrument threshold for detecting abnormal particles) and all particles > 5 µm and > 10 µm (theoretical physiologic threshold for producing embolic syndrome). Significant differences were noted between dosage forms with respect to the number of particulates present from the pre- to the postfiltrate samples.

A reduction in very large particulates (> 10 µm) was observed from the ampules (p=0.034). No differences were noted for the smaller particles (> 1.75 µm, p=0.333; > 5 µm, p=0.229). Of the propofol vial samples, no differences were noted for the larger particles (> 5 µm, p=0.575; > 10 µm, p=0.229). However, a significant increase in particle size was noted for the smallest particles (> 1.75 µm, p=0.0001). This increase in the number of particles in the postfiltrate may reflect the effects of filtration in destabilizing lipid particles.

The use of the 5-µm filter needle significantly reduced the amount of abnormally large particles (> 10 µm) from the ampule dosage form, whereas no difference was observed from the propofol vials. This implies the abnormal particles present were other than lipid and likely to be glass associated with ampule breakage, suggesting the 5-µm filter needle be a standard part of propofol therapy when preparing infusions from ampule dosage forms.

Related Keywords: Propofol injection, Propofol injection, benefits of filtration of, Propofol, particle size distribution from ampules and vials

Related Categories: PEER-REVIEWED

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration
Driscoll David F
, Deaconess Beth Israel, Lawrence Kenneth R, Lewis Keith, Bistrian Bruce R
Mar/Apr 1997
Pg. 118-120

View Sample
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration
Trissel Lawrence A
, Trusley Craig, Kupiec Thomas C, Ben Michel
Jan/Feb 2009
Pg. 78-80

Choosing a Vial Processing Line for Aseptic Compounding: Part 1
Noorian Shaun
, Vahedi Navid
Jul/Aug 2016
Pg. 283-292

Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Zhang Yan-ping
, Trissel Lawrence A
Mar/Apr 1997
Pg. 132-134

Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Johnson Kain
, Sully Andrew, Anthenat Bruce
Jul/Aug 2014
Pg. 270-276

Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
Nov/Dec 2015
Pg. 491-500

Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A
, Stout Richard R, Ron Marcinkoski
Jul/Aug 2013
Pg. 270-280

Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1
Higgins Doral (Neal) O
, Prudom Melanie J, Summers Amy
Jul/Aug 2021
Pg. 298-302

Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
Jan/Feb 2017
Pg. 47-56

Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques
Bjornstad Matthew
, Kosinski Tracy, Burlage Robert
Sep/Oct 2020
Pg. 434-438

Technology Spotlight: Respiratory Vial Sealers
Allen Loyd V Jr
Sep/Oct 2003
Pg. 364-365

Stability of Lidocaine Hydrochloride Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Storms Meredith L
, Stewart James T, Warren Flynn W
Sep/Oct 2002
Pg. 388-390

Stability of Neostigmine Methylsulfate Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Storms Meredith L
, Stewart James T, Warren Flynn W
Nov/Dec 2002
Pg. 475-477

Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs.
Xu Quanyun A
, Trissel Lawrence A, Pham Lien
May/Jun 2004
Pg. 228-230

Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists
Macklin Denise
, Blackburn Paul L
Mar/Apr 2013
Pg. 100-110

Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy
Kosinski Tracy M
, Brown Michael C, Zavala Pedro J
Jan/Feb 2018
Pg. 41-46

PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services
Lees Deril J
Jan/Feb 2014
Pg. 87

Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
May/Jun 2019
Pg. 221-228

Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions
Schnatz Rick
, Hernandex-Cardoso Antonio
May/Jun 2011
Pg. 224-232

Green IV Nutritionals
Karolchyk Scott
Jul/Aug 1999
Pg. 260-261

Return to Top